Navigation Links
UCI receives $5M from Edwards Lifesciences
Date:9/12/2007

Irvine, Calif., September 12, 2007 - UC Irvines Henry Samueli School of Engineering has received a $5 million gift from Edwards Lifesciences Corporation to establish a center focused on researching and developing the next generation of cardiovascular devices.

The Edwards Lifesciences Center for Advanced Cardiovascular Technology will promote interaction and collaboration among students, faculty members and experts by incorporating both undergraduate and graduate programs related to heart and vascular diseases. The programs will be directed by UCIs Department of Biomedical Engineering, and will involve a variety of other disciplines, including students from the Integrated Nanosystems Research Facility, the California Institute for Telecommunications and Information Technology, the Donald Bren School of Information and Computer Sciences, the Beckman Laser Institute, and UCIs Schools of Medicine, Physical Sciences, and Biological Sciences.

The center also will provide a training environment for hosting prominent experts in the field of cardiovascular technology. It will be located in Engineering 3, a new building on the UCI campus scheduled for completion in August 2009.

A national search is under way for a director, who will be charged with establishing a strategic plan and forming a leadership council to determine the centers specific direction.

Our goal is to create an interdisciplinary facility that encourages students, faculty, researchers and visiting scholars to collaborate and exchange new ideas to drive the development of cardiovascular advancements and devices, said Steven C. George, M.D., William J. Link chair and professor of the Department of Biomedical Engineering, who is spearheading the centers development. The Edwards Lifesciences Center will thoroughly examine the integration of numerous disciplines, such as materials science, computer science, advanced imaging and microfabrication, or the manufacturing of devices with precision at levels much smaller than a millimeter, which all have the potential to lead to implantable devices that can help treat cardiovascular disease.

The Department of Biomedical Engineering, which was established in 2002 and is comprised of 16 faculty members, focuses on education, training, research and technology in areas like manufacturing miniature devices, biomedical lasers, developing computer simulations, and designing artificial tissues in the area of tissue engineering to further advance biomedical technology.

We are pleased to closely collaborate with Edwards Lifesciences, an international leader in cardiovascular technology, to develop a center that combines exceptional faculty, resources and tools to advance this evolving field, said Nicolaos G. Alexopoulos, dean of The Henry Samueli School of Engineering. UC Irvine is located in one of the largest medical device company clusters in the world, which I believe uniquely positions us to address this critical health care area and initiate a world class center.

Irvine-based Edwards Lifesciences, which develops products and technologies to treat advanced cardiovascular disease, is granting the multiyear gift through the Edwards Lifesciences Fund. The fund was established to support advancements in knowledge and improvements in quality of life to help those affected by cardiovascular disease, particularly in the communities where the companys employees live and work.

We are proud to partner with a neighbor that is as accomplished and committed to excellence as UC Irvine to establish a center devoted to transformational cardiovascular technology research, said Michael A. Mussallem, Edwards Lifesciences' chairman and CEO. This grant is a testament to our dedication to providing innovative solutions for people fighting cardiovascular disease, as well as our commitment to strengthening the communities in which we live and work.


'/>"/>

Contact: Jason Mednick
jmednick@uci.edu
949-824-5951
University of California - Irvine
Source:Eurekalert

Related biology news :

1. DuPonts first biologically derived polymer receives global recognition
2. OneWorld Health drug receives Orphan designation from U.S. and European regulatory agencies
3. Research on antibiotics receives historical recognition
4. Anthrax test, developed by army and CDC, receives FDA approval
5. Research team receives $7.5 million to study cassava
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2017)... 2, 2017   TapImmune, Inc. (NASDAQ: ... specializing in the development of innovative peptide and ... cancer and metastatic disease, announced today it has ... of a second clinical lot of TPIV 200, ... alpha. The manufactured vaccine product will be used ...
(Date:2/2/2017)... , Feb. 1, 2017  Central to ... and meaningful advances worldwide, The Japan Prize Foundation ... Prize, who have pushed the envelope in their ... and Communication. Three scientists are being recognized with ... achievements that not only contribute to the advancement ...
(Date:1/31/2017)... Mass. , Jan. 31, 2017  Spero ... novel therapies for the treatment of bacterial infections, ... set of antibacterial candidates from Pro Bono Bio ... increased prevalence of multi-drug resistant forms of Gram-negative ... Cantab Anti Infectives Ltd, a PBB group company. ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... Feb. 23, 2017 /PRNewswire/ - The Fight Against Cancer ... Research (OICR) are pleased to report that Fusion Pharmaceuticals ... with Johnson & Johnson Innovation – JJDC, Inc. (JJDC) ... groups HealthCap, TPG Biotechnology Partners, and Genesys Capital, as ... ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... novo clearance to begin marketing the SPEAC® System, the Brain Sentinel® Seizure Monitoring ... home or in healthcare facilities during periods of rest. A lightweight, non-invasive monitor ...
(Date:2/23/2017)... LOS ANGELES , Feb. 23, 2017  Capricor Therapeutics, ... cardiac and other medical conditions, today announced that Linda Marbán, ... at two upcoming investor conferences: Cowen ... 2017 at 10:00 am ET Boston, MA ... 14, 2017 at 9:00 am PT (12:00 pm ET) ...
(Date:2/22/2017)... CA (PRWEB) , ... February 22, 2017 , ... ... announced that is has acquired Kendall Research Systems, LLC (KRS) clinical ... (MIT) that develops neural interface technology for research and clinical applications. The terms ...
Breaking Biology Technology: